| Abbott's XIENCE PRIME Receives CE Mark (ABT) |
| Theraclone, Pfizer Ink Antibody Agreement (PFE) |
| Bristol-Myers Squibb Dividend Announcement (BMY) |
| Australia Court Dismisses Claims Against Merck (MRK) |
| J&J Reaffirms Fiscal 2010 Guidance (JNJ) |
| Abbott and GSK Team on Skin Cancer Test (ABT) |
| Pfizer and Medivation Alzheimer's Results (PFE) |
| J&J to Cut Bonus Targets for Some (JNJ) |
| Boston Scientific to Cut Over 1000 Jobs (BSX) |
| Genzyme Reports 4th Qtr and Full 2009 Results (GENZ) |
| Quest Diagnostics Declares Dividend (DGX) |
| Cephalon Record Sales and Adjusted Net Income (CEPH) |
| Merck Earnings Preview (MRK) |
| Boston Scientific 4th Qtr Results (BSX) |
| UnitedHealth Continues Dividend, Renews Buy Backs (UNH) |
